Respiratory Distress Syndrome, Adult

Respiratory
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

United Therapeutics
United TherapeuticsMD - Silver Spring
1 program
1
Treprostinil Inhalation SolutionPhase 21 trial
Active Trials
NCT02370095Terminated14Est. Nov 2017
NK
Nihon KohdenNEW YORK, NY
1 program
Targeting transpulmonary pressure to avoid VILIN/A1 trial
Active Trials
NCT02342756UnknownEst. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
United TherapeuticsTreprostinil Inhalation Solution
Nihon KohdenTargeting transpulmonary pressure to avoid VILI

Clinical Trials (2)

Total enrollment: 14 patients across 2 trials

NCT02370095United TherapeuticsTreprostinil Inhalation Solution

Treprostinil Sodium Inhalation for Patients At High Risk for ARDS

Start: Feb 2015Est. completion: Nov 201714 patients
Phase 2Terminated
NCT02342756Nihon KohdenTargeting transpulmonary pressure to avoid VILI

Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study

Start: Jan 2015Est. completion: Dec 2017
N/AUnknown

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space